Interestingly, similar sustained therapeutic effects of ASOs have been demonstrated in a previous report in which the infusion of huntingtin-targeting ASOs into the lateral ventricle of HD mice for 2 weeks resulted in sustained phenotypic reversal for at least 4 months, even after huntingtin protein levels had returned to the initial levels.40 The gene discussed is HTT; the disease is Huntington disease.